Macular Edema

Showing NaN - NaN of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Macular Edema, Branch Retinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

Active, not recruiting
  • Macular Edema
  • Branch Retinal Vein Occlusion
  • Phoenix, Arizona
  • +151 more
Aug 4, 2022

Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham

Active, not recruiting
  • Macular Edema
  • +2 more
  • Mesa, Arizona
  • +193 more
Jul 25, 2022

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Macular Edema
  • Retinal Vein Occlusion
  • Phoenix, Arizona
  • +140 more
Jul 20, 2022

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • suprachoroidal CLS-TA
  • +2 more
  • Phoenix, Arizona
  • +91 more
Apr 22, 2021

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • suprachoroidal CLS-TA
  • +2 more
  • Peoria, Arizona
  • +109 more
Mar 18, 2021

Macular Edema Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

Completed
  • Macular Edema
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Graz, Steiermark, Austria
  • +63 more
Jul 15, 2020

Macular Edema Trial in Worldwide (BI 1026706, Placebo)

Completed
  • Macular Edema
  • BI 1026706
  • Placebo
  • Brussel, Belgium
  • +34 more
Mar 18, 2019

Macular Edema Trial in Worldwide (Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321))

Completed
  • Macular Edema
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Graz, Steiermark, Austria
  • +75 more
Sep 12, 2018

Diabetic Retinopathy, Macular Edema Trial in Czechia, Hungary, Slovakia (Anti-PlGF recombinant mAb, 4mg dose, Anti-PlGF

Completed
  • Diabetic Retinopathy
  • Macular Edema
  • Anti-PlGF recombinant monoclonal antibody, 4mg dose
  • Anti-PlGF recombinant monoclonal antibody, 8mg dose
  • Brno, Czechia
  • +12 more
Apr 16, 2018

Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab 0.5 mg/0.05 ml)

Completed
  • Macular Edema
  • Central Retinal Vein Occlusion
  • Ranibizumab 0.5 mg/0.05 ml
  • Parramatta, New South Wales, Australia
  • +77 more
Sep 21, 2016

Visual Impairment, Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab, Dexamethasone implant and sham

Completed
  • Visual Impairment
  • +2 more
  • Augsburg, Germany
  • +63 more
Sep 21, 2016

Diabetes, Macular Edema Trial in Worldwide (VEGF Trap-Eye (BAY86-5321), Macular Laser Photocoagulation (Control))

Completed
  • Diabetes Mellitus
  • Macular Edema
  • VEGF Trap-Eye (BAY86-5321)
  • Macular Laser Photocoagulation (Control)
  • Chatswood, New South Wales, Australia
  • +89 more
Mar 20, 2016

Intravitreal Ranibizumab and Macular Grid-pattern Laser for

Unknown status
  • Macular Edema
  • Budapest, Hungary
  • +2 more
Oct 15, 2009